Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey and currently employs 24,000 full-time employees. The company went IPO on 2022-07-18. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The firm's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.
Follow-Up Questions
Haleon PLC 'in CEO'su kimdir?
Mr. Brian Mcnamara 2022 'den beri şirketle birlikte olan Haleon PLC 'in Chief Executive Officer 'ıdır.
HLNCF hissesinin fiyat performansı nasıl?
HLNCF 'in mevcut fiyatı $4.49 'dir, son işlem günde 0% decreased etti.
Haleon PLC için ana iş temaları veya sektörler nelerdir?
Haleon PLC Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Haleon PLC 'in piyasa değerlemesi nedir?
Haleon PLC 'in mevcut piyasa değerlemesi $39.9B 'dir
Haleon PLC al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 20 analist Haleon PLC için analist derecelendirmeleri gerçekleştirdi, bunlar 8 güçlü al, 9 al, 8 tut, 1 sat ve 8 güçlü sat içermektedir
